Joint BAPEN and British Society of Gastroenterology Symposium on 'Coeliac disease: basics and controversies'. Coeliac disease: optimising the management of patients with persisting symptoms?
The vast majority of patients with coeliac disease will derive benefit from a gluten-free diet. However, some patients will not improve on the gluten-free diet or they will have a relapse of their symptoms. The present review will focus on this group of patients. Definitions for non-responsive coeliac disease and refractory coeliac disease will be provided. The most common reason for recurrent symptoms is continued gluten exposure. Other causes of persisting symptoms are discussed, including alternative causes of villous atrophy or co-existent pathology. Current literature is reviewed, including an initial investigation strategy for patients with persisting symptoms. A pragmatic management plan is described that can be initiated by any clinician. Finally, the current optimal investigational pathway for patients with refractory (or suspected refractory) coeliac disease is discussed and the reported effects of a number of therapeutic options are summarised. The aim of the present article is to provide clinicians with an up-to-date review of the literature in this clinical field and allow them to determine the most appropriate management strategy.
Evans
Kate E
KE
Department of Gastroenterology, Sheffield Teaching Hospitals Trust, Sheffield, UK.
Sanders
David S
DS
D001284:Atrophy / Q000209:etiology; D002446:Celiac Disease / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D003937:Diagnosis, Differential; D055050:Diet, Gluten-Free; D005983:Glutens / Q000276:immunology; D006801:Humans; D007422:Intestines / Q000473:pathology; D055502:Secondary Prevention; D017211:Treatment Failure
D005983:Glutens